"AIO The Eye Surgeons, located in Pennsylvania, is an eye surgery center with advanced technology to bring you the best care possible. With over 45 years of experience, we provide services in eye surgery, care for dry eyes, macular degeneration, glaucoma, LASIK, and many others. Eyesight is one of your most valued senses and unique. We care for your eyes, creating a personalized care or treatment plan to help fix or manage the problem. We want you to have your vision for a long time so let us care for them. We are your visionary eye care. Give us a call today to schedule an appointment."

During the past decade, Associates in Ophthalmology, Ltd conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 8 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Associates in Ophthalmology, Ltd" #1 sponsor was "Allergan" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Lpath, Inc." with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Bausch & Lomb Incorporated" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Associates in Ophthalmology, Ltd" #1 collaborator was "MEDARVA Foundation" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Associates in Ophthalmology, Ltd" are "Geographic Atrophy" (5 trials), "Macular Degeneration" (3 trials), "Age-Related Macular Degeneration" (1 trials), "Age-Related Maculopathy" (1 trials) and "Diabetic Macular Edema" (1 trials). Many other conditions were trialed in "Associates in Ophthalmology, Ltd" in a lesser frequency.

Most popular intervention types in "Associates in Ophthalmology, Ltd" are "Drug" (11 trials), "Other" (3 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Lampalizumab" (2 trials), "Ranibizumab" (2 trials), "Sham" (2 trials) and "0.5 mg Lucentis or 1.25 mg Avastin or 2 mg Eylea" (1 trials). Other intervention names were less common.

The vast majority of trials in "Associates in Ophthalmology, Ltd" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Associates in Ophthalmology, Ltd". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Associates in Ophthalmology, Ltd, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Associates in Ophthalmology, Ltd, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".